Volume 9 Issue 4, December 2006

Prostate News

Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy

• O Al-Salihi
• A Mitra
• H Payne

Performance of tPSA and f/tPSA for prostate cancer in Chinese. A systematic review and meta-analysis

• Y Wang
• G Sun
• T Li

Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification

• Y Ding
• L Xu
• R C Bergan

Androgen deprivation therapy and cardiac function: effects of endurance training

• D S Hydock
• K Y Wonders
• R Hayward

Notch signalling and voltage-gated Na⁺ channel activity in human prostate cancer cells: independent modulation of in vitro motility

• N Scorey
• S P Fraser
• M B A Djamgoz

Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study

• N J Barber
• X Zhang
• G H Muir

Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma

• D Tomas
• M Ulamec
• B Krušlin

Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomy

• N Quatan
• B Meyer
• H Pandha

Manganase superoxide dismutase polymorphism in chronic pelvic pain syndrome patients

• E D Arisan
• S Arisan
• E Ergenekon

Efficacy and tolerability of the dual 5α-reductase inhibitor, dutasteride, in the treatment of benign prostatic hyperplasia in African-American men

• C G Roehrborn
• P Ray

High-intensity focused ultrasound therapy for clinically localized prostate cancer

• H M Lee
• J H Hong
• H Y Choi

Seminal prostasomes inhibit the angiogenesis activity of rat aortic rings

• G H Delves
• A Goyal
• A J Cooper

De novo calcification of liver and nodal metastases in prostate carcinoma

• P Ghosh
• A C Santosa
• T M Downs

British Prostate Group Autumn Meeting 2005

British Prostate Group BAUS Section of Oncology British Uro-Oncology Group